Insufficient scRNA-seq data for expression of LYG2 at single-cell level.
Insufficient scRNA-seq data for expression of LYG2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 68% | 3.08 | 122 / 180 | 66% | 2.67 | 285 / 430 |
esophagus | 70% | 3.33 | 1014 / 1445 | 44% | 0.95 | 81 / 183 |
prostate | 90% | 6.96 | 220 / 245 | 7% | 0.17 | 36 / 502 |
thymus | 92% | 6.72 | 598 / 653 | 2% | 0.04 | 10 / 605 |
intestine | 82% | 4.43 | 792 / 966 | 9% | 0.31 | 47 / 527 |
stomach | 73% | 3.46 | 263 / 359 | 17% | 0.40 | 50 / 286 |
spleen | 90% | 6.11 | 216 / 241 | 0% | 0 | 0 / 0 |
bladder | 81% | 5.00 | 17 / 21 | 6% | 0.17 | 28 / 504 |
brain | 83% | 8.97 | 2205 / 2642 | 3% | 0.05 | 18 / 705 |
skin | 80% | 139.04 | 1455 / 1809 | 3% | 0.10 | 13 / 472 |
lung | 67% | 3.36 | 385 / 578 | 15% | 0.47 | 173 / 1155 |
uterus | 73% | 3.65 | 124 / 170 | 7% | 0.25 | 33 / 459 |
kidney | 70% | 3.82 | 62 / 89 | 9% | 0.21 | 81 / 901 |
adrenal gland | 69% | 2.72 | 178 / 258 | 2% | 0.04 | 5 / 230 |
liver | 58% | 2.11 | 132 / 226 | 8% | 0.24 | 32 / 406 |
blood vessel | 66% | 3.06 | 882 / 1335 | 0% | 0 | 0 / 0 |
breast | 61% | 2.65 | 280 / 459 | 5% | 0.13 | 54 / 1118 |
pancreas | 62% | 2.88 | 204 / 328 | 2% | 0.03 | 3 / 178 |
heart | 61% | 2.69 | 521 / 861 | 0% | 0 | 0 / 0 |
adipose | 56% | 7.07 | 671 / 1204 | 0% | 0 | 0 / 0 |
muscle | 54% | 2.41 | 435 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 49% | 3.02 | 457 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0009253 | Biological process | peptidoglycan catabolic process |
GO_0042742 | Biological process | defense response to bacterium |
GO_0005576 | Cellular component | extracellular region |
GO_0003796 | Molecular function | lysozyme activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LYG2 |
Protein name | Lysozyme g2 (Lysozyme-like, isoform CRA_a) Lysozyme g-like protein 2 (EC 3.2.1.-) Lysozyme g2 |
Synonyms | LYGH hCG_38422 |
Description | FUNCTION: May act as a potent antibacterial protein that may play a role in the innate immunity. . |
Accessions | ENST00000423800.5 [Q86SG7-2] C9JBA4 ENST00000423306.1 C9J4J0 ENST00000409238.5 [Q86SG7-1] ENST00000409679.5 Q86SG7 ENST00000333017.7 [Q86SG7-1] |